Gynecologic Oncology Consult
Gynecologic Oncology Consult
Surgical management of borderline ovarian tumors, part 1
Ovarian-sparing procedures should be offered to patients in the setting of borderline ovarian tumors, with the understanding that they are...
Gynecologic Oncology Consult
Update on secondary cytoreduction in recurrent ovarian cancer
Secondary debulking surgery has been studied since the 1980s with mixed results; these data have shown that the largest barrier to care has been...
Gynecologic Oncology Consult
Update on high-grade vulvar interepithelial neoplasia
Treatment of high-grade vulvar intraepithelial neoplasia should be driven by the clinical characteristics of the vulvar lesions, patients’...
Gynecologic Oncology Consult
Germline genetic testing: Why it matters and where we are failing
Cancer and medical societies recommend universal genetic counseling and testing for patients diagnosed with epithelial ovarian cancer.
Gynecologic Oncology Consult
The role of repeat uterine curettage in postmolar gestational trophoblastic neoplasia
Second uterine evacuation for treatment of nonmetastatic, low-risk postmolar GTN is a reasonable treatment option and one that should be...
Gynecologic Oncology Consult
Estrogen replacement therapy in endometrial cancer survivors
Given the data we have, ERT does not appear to significantly affect oncologic outcomes in low-risk, early-stage endometrial cancer survivors.
Gynecologic Oncology Consult
Racial disparities in endometrial cancer
The disparities seen in endometrial cancer mortality are not new. They can be seen in data for over 30 years and are only widening.
Gynecologic Oncology Consult
The perils of CA-125 as a diagnostic tool in patients with adnexal masses
It is important to have conversations with patients before ordering a CA-125 (or other serum biomarkers) about potential results and their effect...
Gynecologic Oncology Consult
Hormones after cancer: Are they safe?
Hormonal therapy is safe, even beneficial, for many patients with a history of gynecologic cancer, and can significantly improve their quality of...
Gynecologic Oncology Consult
The medical management of early-stage endometrial cancer: When surgery isn’t possible, or desired
Hormonal therapy has long been identified as a highly effective systemic therapy for endometrial cancers, particularly those that are low grade...
Gynecologic Oncology Consult
Optimizing ‘optimal’ in ovarian cancer cytoreduction
While pafolacianine promises to move us closer to a true “R0” (negative margins) resection of ovarian cancer, is this even a feasible goal in a...